IMDX Insight Molecular Diagnostics Inc.: institutional ownership and insider trading
44 funds reported holding $113M of Insight Molecular Diagnostics Inc. in their latest 13F filings; in Q2 2026 funds net sold $2.79M, with 11 new positions and 13 funds selling out; over the last 12 months insiders bought $5.69M and sold $0 on the open market.
Famous investors holding IMDX
- Izzy Englander (Millennium Management): $487K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $65.5K, 0.0% of the portfolio
Largest institutional holders of IMDX
- BROADWOOD CAPITAL INC — $74.8M
- AWM Investment Company, Inc. — $16.7M
- VANGUARD CAPITAL MANAGEMENT LLC — $4.34M
- VANGUARD GROUP INC — $3.95M
- PURA VIDA INVESTMENTS, LLC — $2.86M
- Family Office Research LLC — $2.33M
- GEODE CAPITAL MANAGEMENT, LLC — $1.52M
- JANE STREET GROUP, LLC — $930K
- BlackRock, Inc. (BLK) — $888K
- FNY Investment Advisers, LLC — $869K
Recent IMDX insider trades
- Apr 27, 2026: Broadwood Partners, L.P. bought 570,184 shares ($2.03M)
- Apr 20, 2026: Broadwood Partners, L.P. bought 182,861 shares ($653K)
- Feb 10, 2026: Broadwood Partners, L.P. bought 521,739 shares ($3.00M)
- Feb 7, 2025: Smith Patrick W bought 1,077,600 shares ($2.21M)
5%+ owners
- Neal C. Bradsher: 39.7% (Schedule 13D/A, filed Apr 27, 2026)